“venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies.”
SAN FRANCISCO–(BUSINESS WIRE)–venBio today announced the closing of venBio Global Strategic Fund V (“venBio Fund V”), its fifth life sciences venture capital fund, exceeding its target and closing on approximately $528 million in capital commitments in an oversubscribed fundraise. The firm initiated the fundraise for Fund V in mid-April. Limited partners of Fund V include […]
